Loss of exclusivityApril 2045latest FDA-listed patent expiry
CompanyNobelpharma →See this company's full patent-cliff portfolio
Drug detail
Brand name
HYFTOR
Active ingredient
SIROLIMUS
Strength
0.2%
Dosage form
GEL
Route
TOPICAL
Modality
Small molecule
FDA approval
March 2022
Marketing status
RX
Listed patents
Patent
Expires
Type
12740970
April 2045
product
Regulatory exclusivity
Code
Expires
ODE-391
March 2029
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.